In recent decades, immunotherapy has revolutionized oncology. In the fight against aggressive blood cancers (leukemia, lymphoma and myeloma), CAR-T cells, a therapy that consists of reprogramming some of the patients’ white blood cells to destroy the cancer cells, have become one of the most effective strategies. more promising. . In France, since 2018, several CAR-T treatments have been authorized for marketing, and more than thirty centers are authorized to use them to treat cancer patients. However, the potential of this treatment does not stop there. German researchers presented the results at the annual meeting of the American Society of Hematology on December 9. impressive ” from a trial conducted on 15 patients suffering from autoimmune diseases, including lupus, which is responsible for damaging various tissues such as the skin, blood vessels or kidneys…
Source: Le Figaro
I am John Sinkler, a professional writer and journalist for Buna Times. I specialize in writing about entertainment-related topics and have been doing so for several years now. My work has been featured on multiple platforms and I’m proud to say that it’s gained recognition from many people in the industry. Aside from working at Buna Times, I also write freelance articles for other publications.